Investigating the efficacy of intratumoral delivery of immune checkpoint inhibitors in epithelial ovarian cancer (2018–2020)

Grant type:
AstraZeneca Pty Ltd
Researchers:
  • Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
    Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
Funded by:
AstraZeneca Pty Ltd